While Brand name Approved for Donepezil Aricept All

While
no cure or totally effective medication has yet been created, there are a
number of memory loss medications with FDA approval and on the market at this
time. These medications can only help manage the symptoms and, in few cases,
slow down the rate of progression of the disease. (alzheimers.ie)  However, these medications can be unpopular
because of their unpleasant side effects which can be particularly tough on
older people with the disease. (National institute of aging,
2017)

Current medications on the market in the United States of America:

 

Generic
name

Brand
name

Approved
for

Donepezil

Aricept

All stages

Galantamine

Razadyne

Mild to moderate

Revastigmine

Exelon

Mild to moderate

Memantine

Namenda

Moderate to severe

Donepezil + Memantine

Namzaric

Moderate to severe

(alz.org)

Donepezil:
Used to treat the symptoms of
Alzheimer’s by improving memory of patients, However, does not slowdown or stop
the disease in any way.

 

 

Galantamine:
Used to treat Alzheimer’s and various
other central nervous system diseases. This drug is isolated from plants from
the Amaryllidaceae family such as the
Caucasian snowdrop, the daffodil and the red spider lily.

 

 

 

 

 

 

Revastigmine:
Used f
the treatment of mild to moderate due to Alzheimer’s disease and Parkinson’s
disease. The drug can be administered via transdermal patch which can lessen
the intensity of the side effects. the latter form reduces the prevalence of
side effects.

 

 

 

 

Memantine:
Memantine is used to treat moderate to severe Alzheimer’s disease. It acts on the glutamatergic system by blocking NMDA receptors. This drug has also been used to treat
patients with anxiety disorders, ADHD, OCD and various other neurological
disorders.

Fig.3.)
Chemical formula:  C12H21N
 
 

 

 

 

 

 

 

 

 

 

The first three drugs on this list, Donepezil,
Galantamine and Revastigmine are all from a class of drugs which are called acetylcholinesterase
inhibitor. Cholinesterase
inhibitors are drugs that stop or impede enzymes from breaking down
acetylcholine when it is transported from one cell to another. This means that
the acetylcholine, which is in short supply in people with Alzheimer’s disease,
is not destroyed so quickly and there is more chance of it being passed on to
the next nerve cell. Cholinesterase inhibitors result in higher concentrations
of acetylcholine, leading to increased communication between nerve cells, which
in turn, may temporarily improve or stabilise the symptoms of dementia. Some
people who take cholinesterase inhibitors experience side-effects. Side-effects
from these drugs are most common when someone first administers them but,
fortunately, they often settle down with time. The most likely side effects are
diarrhoea, nausea, vomiting, muscle cramps, lowered blood pressure, insomnia,
fatigue and loss of appetite. Other reported side effects include falls and
dizziness. If the dose is increased gradually the likelihood of side effects is
lower. When prescribing these drugs, the doctor must ensure they are aware of
the patient’s medical history because they can be harmful in people with a
history of peptic ulcers, asthma, liver or kidney disease, or a very slow heart
rate.  (dementia australia, 2006)

 

 

 

 

 

 

 

 

 

 

The fourth drug on the list, Memantine, is a different type
of drug which acts on the glutamatergic system by blocking NMDA receptors.

 

(what type
of drug memantine is)

 

 

 

 

 

 

 

 

 

Bibliography

alz.org. (n.d.). Medications
for memory loss. Retrieved from alz.org:
https://www.alz.org/alzheimers_disease_standard_prescriptions.asp
alzheimers.ie.
(n.d.). Treating dementia. Retrieved from alzheimers.ie:
https://www.alzheimer.ie/Living-with-dementia/I-have-Dementia/Treatments.aspx
dementia australia.
(2006). Drug treatments for Alzheimer’s disease. Retrieved from
https://www.dementia.org.au/files/helpsheets/Helpsheet-DementiaQandA01-CholinesteraseInhibitors_english.pdf
National
institute of aging. (2017, may 18). How is alzheimer’s disease treated.
Retrieved from nia.nih.gov:
https://www.nia.nih.gov/health/how-alzheimers-disease-treated
 

 

Picture references:

Fig.1) What
is Donepezil. Retrieved from http://donepezil.com/

Fig.2 What are Acetylcholinesterase inhibitors. Retrieved
from https://peaknootropics.com/using-acetylcholinesterase-inhibitors-nootropics/

 

BACK TO TOP